The Penn Comprehensive ALS Center — Philadelphia, Pennsylvania

The Penn Comprehensive ALS Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

The Penn Comprehensive ALS Center has participated in 1 clinical trials.

Therapeutic areas: Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuromuscular Diseases.

Sponsors: Amylyx Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Penn Comprehensive ALS Center?

The Penn Comprehensive ALS Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Penn Comprehensive ALS Center conducted?

The Penn Comprehensive ALS Center has 1 clinical trials on record. Their work covers Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuromuscular Diseases.

Is The Penn Comprehensive ALS Center accredited by Crixeo Health?

The Penn Comprehensive ALS Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Penn Comprehensive ALS Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.